Viewing Study NCT04387591



Ignite Creation Date: 2024-05-06 @ 2:38 PM
Last Modification Date: 2024-10-26 @ 1:35 PM
Study NCT ID: NCT04387591
Status: COMPLETED
Last Update Posted: 2021-03-03
First Post: 2020-05-10

Brief Title: Fus Subcutaneous Needling Treatment for Biceps Tendinopathy
Sponsor: China Medical University Hospital
Organization: China Medical University Hospital

Study Overview

Official Title: Effect on Symptomatic Release of Remote Fus Subcutaneous Needling on Patients With Biceps Tendinopathy
Status: COMPLETED
Status Verified Date: 2021-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Biceps tendinopathy is a common cause in shoulder-pain symptoms The major mechanism is overuse of the biceps muscles The long-term accumulated and poor repaired trauma causes myofascial trigger points in the related musclesWe will conduct the randomized open label experiment to evaluate the immediate short-term and long-term effect of Fus subcutaneous needling FSN
Detailed Description: Biceps tendinopathy is a common cause in shoulder-pain symptoms The major mechanism is overuse of the biceps muscles The long-term accumulated and poor repaired trauma causes myofascial trigger points in the related muscles Common symptoms are pain in the anterior shoulders and radiating pain in the biceps Pain can be further elicited with lifting pulling and repetitive overhead activity Therefore it can have a major impact on the patients activity of daily life

Fus subcutaneous needling FSN as one of the dry needle treatments performed by swaying a disposable Fus subcutaneous needle parallel to the underlying muscles after penetrating the skin to the subcutaneous fascia With the reperfusion activities myofascial pain and soft tissue pain caused by myofascial trigger points can be decreased effective simultaneously So far there is no solid research or clinical trial to evaluate the efficacy of the treatment yet

We will conduct the randomized open label experiment to evaluate the immediate short-term and long-term effect of FSN Outcome measures include visual analog scale shoulder pain and disability index pressure pain threshold muscle tone changes and ultrasonographic evaluaton of biceps peritendinous effusion

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None